#ClinicalTrialsSoWhite: How Drug Makers Are Using COVID-19 To Improve Trial Diversity

Pandemic Highlights Trials’ Minority Underrepresentation

 
• By Alaric DeArment
Closed up finger on keyboard with word CLINICAL TRIALS
Clinical trial diversity is a longtime topic of discussion, but COVID-19 has highlighted its importance • Source: Shutterstock

More from Clinical Trials

More from R&D